EMA recommends ten new medicines
The EMA’s expert committee, CHMP, recommends ten medicines for approval at its meeting in February 2024. Several of the drugs come from large international pharmaceutical companies.
Af SEBASTIAN BRAUER HAGEL
The mood was probably positive during the February meeting of the EMA’s expert committee, Committee for Medicinal Products for Human Use (CHMP), which subsequently recommends a total of ten medicines for approval. At the same time, six medicines already on the market have been recommended to have their indication extended, the European Medicines Agency’s website informs.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
